Sanofi and Regeneron’s would-be blockbuster clears FDA hurdle, but questions remain

Damian Garde A cholesterol-slashing treatment from Sanofi and Regeneron won over a key FDA panel, signaling a likely approval but leaving unclear just which patients should get the ...

Sanofi buys into NeuroVive’s cardio drug in Korea

Damian Garde Sanofi is betting on the promise of NeuroVive Pharmaceutical's top prospect, buying the South Korean rights to the biotech's Phase III cardiovascular drug. FierceBiotech ...

Exec pay critics bristle as Sanofi lines pockets of Viehbacher, Brandicourt

Carly Helfand Sanofi CEOs past and present are in line for big payouts after yesterday's annual meeting, as resolutions passed to line the pockets of ousted skipper Chris Viehbacher ...

Sanofi expands PA vaccine facility to prepare for dengue launch

Tracy Staton Sanofi plans to manufacture its highly anticipated dengue vaccine in a French facility built specifically for the product. But Sanofi Pasteur's vaccine operation in ...

Sanofi makes it official–Brandicourt is its man

Eric Palmer Sanofi confirmed the rumors today, naming Paris-trained Olivier Brandicourt its new CEO. Brandicourt, who the French drugmaker stole away from the top pharma spot at Bayer ...

Bayer’s Brandicourt said to top Sanofi CEO list: Bloomberg

Eric Palmer Sanofi Chairman Serge Weinberg recently brushed away suggestions that the French drugmaker was having a hard time finding someone who wanted to be CEO of the company. Now ...

UPDATED: Sanofi drops the ax on 100 R&D staffers in Boston reorganization

John Carroll Just as it was spreading word of a big new development partnership this morning, Sanofi dropped the ax on about 100 employees in a reorganization of its R&D operations. FierceBiotech ...

Sanofi taps Adimab for antibody R&D

Damian Garde Sanofi inked a deal with the antibody discovery experts at Adimab, partnering up to generate a fleet of potential medicines. FierceBiotech News

Look for a new Sanofi CEO by March, says chairman, as earnings top forecast

Tracy Staton Striking out in our CEO search? Not us, says Sanofi. Chairman Serge Weinberg says the board is talking to a "limited number of candidates" and expects to make ...

Sanofi Chairman says French tax burden a killer for attracting execs

Eric Palmer Sanofi Chairman Serge Weinberg, who must replace Chris Viehbacher after ousting the outspoken CEO, has publicly expressed his own exasperation with France, saying its high ...

French Smith & Nephew CEO Olivier Bohuon seen as solid pick for top Sanofi job

Eric Palmer Olivier Bohuon, the CEO of artificial hip and knee maker Smith & Nephew may have a leg up over other potential candidates to take the reins of drugmaker Sanofi after ...

Sanofi canned its outspoken CEO. Will the board go French with a replacement?

Tracy Staton CEO Chris Viehbacher's future may not have been on the Sanofi board's agenda Monday. But it was on Wednesday. The directors issued a statement after an 8 a.m. meeting, ...
© 2018 Global Regulatory Science. All rights reserved. Site Admin · Entries RSS · Comments RSS